Clinical trial · Observational
A Study to Explore Prognoses of the Patients With N2 Non-small Cell Lung Cancer
A Multi-centre Real-world Non-interventional Observational Study to Compare Prognoses of the Chinese Patients With N2 Non-small Cell Lung Cancer Who Received Adjuvant Chemotherapies and Perioperative Chemotherapies After Surgeries
NCT03451526CI-TRIAL-00033014completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The trial was designed to compare the effectiveness of radical resections of lung cancer plus adjuvant chemotherapies and perioperative chemotherapies in the patients with N2 non-small cell lung cancer
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Non-small Cell Lung Cancer | Lung Non-Small Cell Carcinoma | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Surgeries | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- Surgeries+adjuvant chemotherapies
- description
- Patients who received radical resection of lung cancer + adjuvant chemotherapies
- interventionNames
- Procedure: Surgeries
- label
- Perioperative chemotherapies
- description
- Patients who received perioperative chemotherapies
- interventionNames
- Procedure: Surgeries
Primary outcomes (1)
- measure
- Overall survival
- timeFrame
- 2014 - 2017
- description
- Overall survival
Secondary outcomes (1)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patients with radical resection of lung cancer enrolled from 2014 to 2019; * Pathologically diagnosed patients with non-small cell lung cancer; * Patients with age \> 18 years old; * Patients who did not receive chest surgeries before hospitalization; * Patients with N2 lymph nodes (+) after surgeries; * Patients who received lymphadenectomy for one group or more groups of lymph nodes; Exclusion Criteria: * Patients with second primary tumors or multiple primary tumors;
References
Publications (0)
Data not yet available
No reference posted for this study.